Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Older Patients × Decitabine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 7 Myelodysplastic Syndromes 2 TP53 1 Primary Malignant Neoplasm of Ovary 1 Older Patients 1 Hodgkin Disease 1 GATA2 Deficiency 1 Allogeneic Hematopoietic Stem Cell Transplantation 1

Interventions

venetoclax 1 fludarabine 1 Influenza Vaccines 1 Decitabine 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07052422 2025-07-04

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting

Older Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡